136 related articles for article (PubMed ID: 37936787)
41. [The prevalence of beta-thalassemia heterozygotes compound alpha-thalassemia in Guangdong district].
Han J; Zeng R; Hu B
Zhonghua Xue Ye Xue Za Zhi; 2001 Oct; 22(10):514-6. PubMed ID: 11769674
[TBL] [Abstract][Full Text] [Related]
42. Interaction of an α-Globin Gene Triplication with β-Globin Gene Mutations in Iranian Patients with β-Thalassemia Intermedia.
Farashi S; Bayat N; Faramarzi Garous N; Ashki M; Montajabi Niat M; Vakili S; Imanian H; Zeinali S; Najmabadi H; Azarkeivan A
Hemoglobin; 2015; 39(3):201-6. PubMed ID: 26084319
[TBL] [Abstract][Full Text] [Related]
43. Hb S (
Azarkeivan A; Cohan N; Niazkar HR; Azizi A; Rad F
Hemoglobin; 2020 Mar; 44(2):109-112. PubMed ID: 32370567
[TBL] [Abstract][Full Text] [Related]
44. Association Between Genetic Polymorphisms and Hb F Levels in Heterozygous β-Thalassemia 3.5 kb Deletions.
Tepakhan W; Kanjanaopas S; Srewaradachpisal K
Hemoglobin; 2020 Sep; 44(5):338-343. PubMed ID: 32878504
[TBL] [Abstract][Full Text] [Related]
45. Multicenter study of the molecular basis of thalassemia intermedia in different ethnic populations.
Verma IC; Kleanthous M; Saxena R; Fucharoen S; Winichagoon P; Raizuddin S; Khan SN; Akbari MT; Izadyar M; Kotea N; Old JM; Ioannou PA; Khan B
Hemoglobin; 2007; 31(4):439-52. PubMed ID: 17994378
[TBL] [Abstract][Full Text] [Related]
46. The correlation of α-globin gene mutations and the XmnI polymorphism with clinical severity of Hb E/β-thalassemia.
Charoenkwan P; Teerachaimahit P; Sanguansermsri T
Hemoglobin; 2014; 38(5):335-8. PubMed ID: 25238043
[TBL] [Abstract][Full Text] [Related]
47. The gamma chain heterogeneity of fetal hemoglobin in black beta-thalassemia and HPFH heterozygotes.
Huisman TH; Gravely ME; Webber B; Okonjo K; Henson J; Reese AL
Blood; 1981 Jul; 58(1):62-70. PubMed ID: 6165415
[TBL] [Abstract][Full Text] [Related]
48. Spectrum of beta-globin gene mutations among thalassemia patients in the West Bank region of Palestine.
Darwish HM; El-Khatib FF; Ayesh S
Hemoglobin; 2005; 29(2):119-32. PubMed ID: 15921164
[TBL] [Abstract][Full Text] [Related]
49. Spectrum of beta thalassemia mutations and HbF levels in the heterozygous Moroccan population.
Lemsaddek W; Picanço I; Seuanes F; Mahmal L; Benchekroun S; Khattab M; Nogueira P; Osório-Almeida L
Am J Hematol; 2003 Jul; 73(3):161-8. PubMed ID: 12827652
[TBL] [Abstract][Full Text] [Related]
50. BCL11A is a major HbF quantitative trait locus in three different populations with beta-hemoglobinopathies.
Sedgewick AE; Timofeev N; Sebastiani P; So JCC; Ma ESK; Chan LC; Fucharoen G; Fucharoen S; Barbosa CG; Vardarajan BN; Farrer LA; Baldwin CT; Steinberg MH; Chui DHK
Blood Cells Mol Dis; 2008; 41(3):255-258. PubMed ID: 18691915
[TBL] [Abstract][Full Text] [Related]
51. [Prevalence and molecular analysis of β-thalassemia in children of Han ethnicity in Chongqing city].
Yao XY; Zhang YM; Qin ZZ; Fan R; Zou L; Chen SP; Zhang L; Xie Q; Zhong XY; Xian Y; Yu J
Zhonghua Er Ke Za Zhi; 2013 Jul; 51(7):518-22. PubMed ID: 24267133
[TBL] [Abstract][Full Text] [Related]
52. Targeted Next-Generation Sequencing Reveals a Large Novel β-Thalassemia Deletion that Removes the Entire
Yin ZZ; Yao J; Wei FX; Chen CY; Yan HM; Zhang M
Hemoglobin; 2022 Sep; 46(5):290-295. PubMed ID: 36412578
[TBL] [Abstract][Full Text] [Related]
53. Utility of the multivariate approach in predicting β-thalassemia intermedia or β-thalassemia major types In Iranian patients.
Banan M; Bayat H; Namdar-Aligoodarzi P; Azarkeivan A; Kamali K; Daneshmand P; Zaker-Kandjani B; Najmabadi H
Hemoglobin; 2013; 37(5):413-22. PubMed ID: 23805990
[TBL] [Abstract][Full Text] [Related]
54. Thrombophilic mutations among Southern Iranian patients with sickle cell disease: high prevalence of factor V Leiden.
Rahimi Z; Vaisi-Raygani A; Nagel RL; Muniz A
J Thromb Thrombolysis; 2008 Jun; 25(3):288-92. PubMed ID: 17619828
[TBL] [Abstract][Full Text] [Related]
55. Co-heredity of silent CAP + 1570 T>C (HBB:c*96T>C) defect and severe β-thal mutation: a cause of mild β-thalassemia intermedia.
Vinciguerra M; Passarello C; Cassarà F; Leto F; Cannata M; Calvaruso G; Di Maggio R; Renda D; Maggio A; Giambona A
Int J Lab Hematol; 2016 Feb; 38(1):17-26. PubMed ID: 26418075
[TBL] [Abstract][Full Text] [Related]
56. Molecular epidemiological study of alpha- and beta-thalassemia in Sihui city.
Tan JR; Li WJ; Ma JY; Mo QH; Li LY; Jia SQ; Lao XW; Li LY; He RQ; Xu XM
Di Yi Jun Yi Da Xue Xue Bao; 2003 Jul; 23(7):716-9. PubMed ID: 12865230
[TBL] [Abstract][Full Text] [Related]
57. Existence of HbF Enhancer Haplotypes at
Cyrus C; Vatte C; Borgio JF; Al-Rubaish A; Chathoth S; Nasserullah ZA; Jarrash SA; Sulaiman A; Qutub H; Alsaleem H; Alzahrani AJ; Steinberg MH; Ali AK
Biomed Res Int; 2017; 2017():1972429. PubMed ID: 28280727
[No Abstract] [Full Text] [Related]
58. Differences in response to fetal hemoglobin induction therapy in beta-thalassemia and sickle cell disease.
Fathallah H; Taher A; Bazarbachi A; Atweh GF
Blood Cells Mol Dis; 2009; 43(1):58-62. PubMed ID: 19346141
[TBL] [Abstract][Full Text] [Related]
59. Hb S/
Belisário AR; Carneiro-Proietti AB; Sabino EC; Araújo A; Loureiro P; Máximo C; Flor-Park MV; Rodrigues DDOW; Ozahata MC; McClure C; Mota RA; Gomes Moura IC; Custer B; Kelly S;
Hemoglobin; 2020 Jan; 44(1):1-9. PubMed ID: 32172616
[TBL] [Abstract][Full Text] [Related]
60. A study on the genotype frequency of -158 Gγ (C→T)
Moez P; Moftah R; Mahmoud HA
J Genet; 2018 Jun; 97(2):505-511. PubMed ID: 29932071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
